MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
Introduction In this secondary analysis of the Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment (MARCH) trial, we evaluated what demographic and clinical factors were associated with reduction in weight. We also assessed the effects of acarbose and metformin treatment on weig...
Enregistré dans:
Auteurs principaux: | Na Wang, Jin-Ping Zhang, Xiao-Yan Xing, Zhao-Jun Yang, Bo Zhang, Xin Wang, Wen-Ying Yang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Termedia Publishing House
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f47e2d59273c4b97bcd307641ba863bb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome
par: Nielson T. Baxter, et autres
Publié: (2019) -
Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
par: Song L, et autres
Publié: (2021) -
A Combination Approach in Inhibiting Type 2 Diabetes-Related Enzymes Using <i>Ecklonia radiata</i> Fucoidan and Acarbose
par: Blessing Mabate, et autres
Publié: (2021) -
Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial
par: María Molina-Vega, et autres
Publié: (2022) -
Principles of Rapid Weight Loss in Female Sambo Athletes
par: Nikola Todorović, et autres
Publié: (2021)